THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹5,646.8 Cr | -5.5% | -12.1% | 59.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹108,556.0 Cr | -3% | 0.6% | 21.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹96,336.2 Cr | -4.9% | -6.2% | 4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,390.1 Cr | -4.5% | -8.6% | 36.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹34,108.8 Cr | -5% | -10.5% | 8.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,800.9 Cr | -1.6% | -6.5% | -10.1% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -5.5% |
-12.1% |
59.2% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses